Party Time: Brokers Just Made Major Increases To Their BeiGene, Ltd. (NASDAQ:BGNE) Earnings Forecasts

Simply Wall St14:59 ET

BeiGene Confirms Information Accuracy, Seeks Exemptions

TipRanksAug 14 10:07 ET

BeiGene Schedules Key Financial Review Meeting

TipRanksAug 14 07:08 ET

BEIGENE: DATE OF AUDIT COMMITTEE MEETING

Hong Kong Stock ExchangeAug 14 06:35 ET · Announcements

Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028: First Anti TIGIT Antibody to Get Approval Within Next 5 Years - ResearchAndMarkets.com

BusinesswireAug 13 13:10 ET

BofA Securities Maintains BeiGene(BGNE.US) With Hold Rating, Raises Target Price to $198

Moomoo NewsAug 13 10:32 ET · Ratings